Articles producció científica> Ciències Mèdiques Bàsiques

Voriconazole minimum inhibitory concentrations are predictive of treatment outcome in experimental murine infections by Candida glabrata

  • Identification data

    Identifier: PC:1547
    Authors:
    Javier LuqueMarta SanchisMariana CastanheiraAdela Martin-VicenteDeanna A. SuttonAnnette W. FothergillNathan P. WiederholdJosep Guarro
    Abstract:
    DOI: 10.1016/j.ijantimicag.2015.12.020
  • Others:

    Author, as appears in the article.: Javier Luque; Marta Sanchis; Mariana Castanheira; Adela Martin-Vicente; Deanna A. Sutton; Annette W. Fothergill; Nathan P. Wiederhold; Josep Guarro
    Department: Ciències Mèdiques Bàsiques
    URV's Author/s: CAPILLA LUQUE, JAVIER; Marta Sanchis; Mariana Castanheira; Adela Martin-Vicente; Deanna A. Sutton; Annette W. Fothergill; Nathan P. Wiederhold; GUARRO ARTIGAS, JOSEP
    Keywords: voriconazole fungal infection Candida glabrata
    Abstract: In this study, 27 clinical isolates of Candida glabrata with voriconazole (VRC) minimum inhibitory concentrations (MICs) ranging from ¿0.03 ¿g/mL to 8 ¿g/mL were tested to determine whether in vitro data are predictive of in vivo efficacy. The efficacy of VRC administered at 40 mg/kg was assayed in a neutropenic murine model of disseminated infection by C. glabrata. The reduction in fungal tissue burden in the kidneys was used as a marker of treatment efficacy. VRC reduced the fungal tissue burden in mice infected with strains that had MICs below the epidemiological cut-off value (ECV) of 0.25 ¿g/mL. Variable efficacy of VRC was obtained when the MIC equalled the ECV, and VRC was ineffective when the MIC exceeded the ECV. These results suggest that the use of in vitro data could be useful to predict the outcome for infections by this fungus.
    Research group: Unitat de Micologia i Microbiologia Ambiental
    Thematic Areas: Health sciences Ciencias de la salud Ciències de la salut
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 0924-8579
    Author identifier: 0000-0002-0765-6403; 0000-0002-7839-7568
    Record's date: 2016-05-24
    Last page: 288
    Journal volume: 47
    Papper version: info:eu-repo/semantics/acceptedVersion
    Link to the original source: https://www.sciencedirect.com/science/article/abs/pii/S0924857916000431
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Article's DOI: 10.1016/j.ijantimicag.2015.12.020
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2016
    First page: 286
    Publication Type: Article Artículo Article
  • Keywords:

    Voriconazol
    Micosi
    Càndida glabrata
    voriconazole
    fungal infection
    Candida glabrata
    Health sciences
    Ciencias de la salud
    Ciències de la salut
    0924-8579
  • Documents:

  • Cerca a google

    Search to google scholar